World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 93 10746 10091 1021 974 622 39560

Usha Chakravarthy publications per year

The chart shows the history of publications by Usha Chakravarthy between 1984 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Usha Chakravarthy published across 42 years, from 1984 to 2025, averaging 15.4 papers a year. Output peaked at 49 publications in 2021. 43 of the 648 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1984 to 2025. Vertical axis: number of publications, 0 to 49. Peak 49 publications in 2021. 1984: 1 publication 1985: 1 publication 1986: 2 publications 1987: 2 publications 1988: 0 publications 1989: 2 publications 1990: 0 publications 1991: 1 publication 1992: 4 publications 1993: 2 publications 1994: 3 publications 1995: 5 publications 1996: 6 publications 1997: 8 publications 1998: 5 publications 1999: 10 publications 2000: 5 publications 2001: 5 publications 2002: 11 publications 2003: 13 publications 2004: 14 publications 2005: 10 publications 2006: 21 publications 2007: 27 publications 2008: 24 publications 2009: 22 publications 2010: 12 publications 2011: 17 publications 2012: 17 publications 2013: 25 publications 2014: 26 publications 2015: 31 publications 2016: 39 publications 2017: 43 publications 2018: 20 publications 2019: 46 publications 2020: 35 publications 2021: 49 publications 2022: 22 publications 2023: 19 publications 2024: 24 publications 2025: 19 publications
1984 2025

648 publications in total across all disciplines

View publications per year as a table
Usha Chakravarthy: publications per year, 1984 to 2025
Year Publications
1984 1
1985 1
1986 2
1987 2
1988 0
1989 2
1990 0
1991 1
1992 4
1993 2
1994 3
1995 5
1996 6
1997 8
1998 5
1999 10
2000 5
2001 5
2002 11
2003 13
2004 14
2005 10
2006 21
2007 27
2008 24
2009 22
2010 12
2011 17
2012 17
2013 25
2014 26
2015 31
2016 39
2017 43
2018 20
2019 46
2020 35
2021 49
2022 22
2023 19
2024 24
2025 19
Total 648
Download as CSV

Usha Chakravarthy publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Usha Chakravarthy sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 621–640 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 622 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386 622
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Usha Chakravarthy D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Usha Chakravarthy sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 92–93 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839 93
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Usha Chakravarthy is affiliated with Queen's University Belfast in the United Kingdom and has an extensive body of research primarily focused on medicine with a significant specialization in ophthalmology.

Their research spans several subfields, including ophthalmology, radiology, nuclear medicine and imaging, molecular biology, neurology, and pathology and forensic medicine. The main topics covered by their work include retinal diseases and treatments, retinal imaging and analysis, retinal and optic conditions, glaucoma and retinal disorders, retinal development and disorders, retinal and macular surgery, and retinopathy of prematurity studies.

Chakravarthy has contributed notably to the following recent publications:

  • Age-related macular degeneration, 2021, Nature Reviews Disease Primers
  • A foundation model for generalizable disease detection from retinal images, 2023, Nature
  • Polypoidal Choroidal Vasculopathy, 2020, Ophthalmology
  • Age-Related Macular Degeneration, 2024, JAMA
  • Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial, 2020, The Lancet

Frequent co-authors in their research include Tünde Pető, Ruth Hogg, Andrew Lotery, Paul J. Foster, and Sobha Sivaprasad. These collaborations highlight a network of researchers involved in related fields of eye disease and vision science.

Chakravarthy's work is published predominantly in journals focused on ophthalmology and eye health. The leading publication venues for their work are:

  • Ophthalmology Retina
  • British Journal of Ophthalmology
  • Eye
  • Ophthalmology
  • American Journal of Ophthalmology

Best Publications

  • Global Causes of Blindness and Distance Vision Impairment 1990-2020: A Systematic Review and Meta-Analysis

    Seth R Flaxman;Rupert R A Bourne;Serge Resnikoff;Serge Resnikoff;Peter Ackland

  • Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis

    Rupert R A Bourne;Seth R Flaxman;Tasanee Braithwaite;Maria V Cicinelli

  • Clinical Classification of Age-related Macular Degeneration

    Frederick L. Ferris;C.P. Wilkinson;Alan Bird;Usha Chakravarthy

  • Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis

    Usha Chakravarthy;Tien Y. Wong;Tien Y. Wong;Astrid Fletcher;Elisabeth C Piault

  • Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.

    Usha Chakravarthy;Simon P. Harding;Chris A. Rogers;Susan M. Downes

  • Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

    Usha Chakravarthy;Simon P Harding;Chris A Rogers;Susan M Downes

  • Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: the IN•OCT consensus.

    Giovanni Staurenghi;Srinivas Sadda;Usha Chakravarthy;Richard F. Spaide

  • The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis.

    Tien Wong;Usha Chakravarthy;Ronald Klein;Paul Mitchell

  • Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3.

    Srinivas R. Sadda;Robyn Guymer;Frank G. Holz;Steffen Schmitz-Valckenberg

  • Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA).

    Ursula Schmidt-Erfurth;Jose Garcia-Arumi;Francesco Bandello;Karina Berg

  • A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration.

    Anne E Hughes;Nick Orr;Hossein Esfandiary;Martha Diaz-Torres

  • Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE).

    Cristina A. Augood;Johannes R. Vingerling;Paulus T. V. M. de Jong;Usha Chakravarthy

  • Prevalence of Age-Related Macular Degeneration in Europe: The Past and the Future

    Johanna M. Colijn;Gabriëlle H.S. Buitendijk;Elena Prokofyeva;Dalila Alves

  • Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial

    Sobha Sivaprasad;A Toby Prevost;Joana C Vasconcelos;Amy Riddell

  • Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.

    U Chakravarthy;A P Adamis;E T Cunningham

  • Defining response to anti-VEGF therapies in neovascular AMD

    W M Amoaku;U Chakravarthy;R Gale;M Gavin

  • Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study

    Usha Chakravarthy;R. F. Houston;D. B. Archer

  • StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial

    James E. Neffendorf;James E. Neffendorf;Riti Desai;Yanzhong Wang;Joanna Kelly

  • Age related macular degeneration: Better tools are needed to measure quality of life and visual outcomes

    Usha Chakravarthy

Frequent Co-Authors

Astrid E. Fletcher
Astrid E. Fletcher London School of Hygiene & Tropical Medicine
Andrew J. Lotery
Andrew J. Lotery University of Southampton
Ian S. Young
Ian S. Young Queen's University Belfast
Barnaby C Reeves
Barnaby C Reeves University of Bristol
Jesús Vioque
Jesús Vioque Miguel Hernandez University
Robyn H. Guymer
Robyn H. Guymer University of Melbourne
Srinivas R. Sadda
Srinivas R. Sadda University of California, Los Angeles
Paulus T. V. M. de Jong
Paulus T. V. M. de Jong University of Amsterdam
Christopher Patterson
Christopher Patterson Queen's University Belfast

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, several related online degrees offer more flexible paths into healthcare careers. Many students look into nursing programs, which can often be completed online with minimal onsite requirements. For those already holding credentials, an rn to bsn with no clinicals pathway allows registered nurses to advance their qualifications entirely online, making it more convenient for working professionals.

Those aiming for leadership or advanced practice roles may consider doctoral programs. There are short dnp programs available online that accelerate your journey to a Doctor of Nursing Practice degree. If you’re seeking flexibility, a dnp program without clinical hours may also appeal, allowing you to focus on coursework and leadership rather than hands-on clinicals.

For students wanting to quickly enter the nursing profession, a fast lpn program can help you become a Licensed Practical Nurse in a shorter timeframe. These online programs make healthcare careers more accessible, regardless of whether your goal is to provide patient care directly or move into advanced clinical practice.

Best Scientists Citing Usha Chakravarthy

Trending Scientists

Recently Published Articles